ERA

Download the full-sized PDF of Lipopolysaccharide Inhibits Interleukin–13-induced Chemokine (C-C motif) Ligand 26 in Human Airway Epithelial Cells: Possible Role in Eosinophil Chemotaxis in Allergic AsthmaDownload the full-sized PDF

Analytics

Share

Permanent link (DOI): https://doi.org/10.7939/R34M91Q8D

Download

Export to: EndNote  |  Zotero  |  Mendeley

Communities

This file is in the following communities:

Graduate Studies and Research, Faculty of

Collections

This file is in the following collections:

Theses and Dissertations

Lipopolysaccharide Inhibits Interleukin–13-induced Chemokine (C-C motif) Ligand 26 in Human Airway Epithelial Cells: Possible Role in Eosinophil Chemotaxis in Allergic Asthma Open Access

Descriptions

Other title
Subject/Keyword
Allergic Asthma
Interleukin 13
Type of item
Thesis
Degree grantor
University of Alberta
Author or creator
Alotaibi,Dhaifallah S
Supervisor and department
Vliagoftis, Harissios (Medicine)
Examining committee member and department
Befus, Dean (Medicine)
Stafford, James (Biological Sciences)
Madsen, Karen (Medicine)
Department
Department of Medicine
Specialization

Date accepted
2017-08-04T08:35:14Z
Graduation date
2017-11:Fall 2017
Degree
Master of Science
Degree level
Master's
Abstract
Background Allergic asthma is characterized by increased level of Interleukin-13 (IL-13) in the lungs. IL-13 promotes eosinophilic infiltration in the airways by stimulating airway epithelial cells to release eotaxin-3 (CCL26) through the Janus activated kinase-2 (JAK-2)/signal transducer and activator of transcription 6 (STAT6) pathway. Eosinophil accumulation in the airways is a hallmark of allergic asthma. There is also evidence that bacterial products, such as LPS, affect the release of eosinophil chemotactic factors and may alter eosinophil accumulation in peripheral tissues. However, the effects of LPS on airway eosinophilia are incompletely understood. Thus, our aim was to study the effects of LPS on IL-13 -induced CCL26 induction in airway epithelial cells and the mechanisms of these effects. Methods We used LPS to mimic the bacterial insults on the airway epithelium. The human bronchial epithelial cell line BEAS-2B was stimulated with IL-13 (20 ng/ml) alone or in combination with LPS (10 μg/ml) for 24 hr. CCL26 mRNA levels were measured using quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) and CCL26 protein was measured in the supernatants of these cells using ELISA. STAT6 phosphorylation was measured by western blot. For NF-kB inhibition, BEAS-2B cells were pre-treated with 3 different NF-kB inhibitors, curcumin (10 μM), arctigenin (1 μM), and bengamide B (1 μM), for 2 hr before activation with IL-13 and/or LPS. Results BEAS-2B cell activation with IL-13 for 24 hr strongly induced CCL26 mRNA expression (78.3 ± 3.9 fold over unstimulated cells, n=13, p < 0.001) and the release of CCL26 protein (1462 ± 55.1 pg/ml , while there was no detection of CCL26 protein release in unstimulated cells, n=13, p < 0.001). Simultaneous treatment of BEAS-2B cells with LPS inhibited IL-13 -induced CCL26 expression (n=13, p < 0.001) and CCL26 protein release (n=13, p < 0.001). IL-13 also induced STAT6 phosphorylation in BEAS-2B cells, which peaked at 30 min. STAT6 phosphorylation, was attenuated when cells were activated by IL-13 in the presence of LPS (n=3, p < 0.05). Pre- incubation of the cells with NF-kB inhibitors prevented the LPS effect on IL-13 -induced CCL26 upregulation and STAT6 phosphorylation. Conclusions LPS, a TLR-4 ligand, inhibits the effects of IL-13 on CCL26 expression in airways epithelial cells. This effect may be dependent on LPS interfering with JAK2/STAT6 signaling through NF- kB activation.
Language
English
DOI
doi:10.7939/R34M91Q8D
Rights
This thesis is made available by the University of Alberta Libraries with permission of the copyright owner solely for the purpose of private, scholarly or scientific research. This thesis, or any portion thereof, may not otherwise be copied or reproduced without the written consent of the copyright owner, except to the extent permitted by Canadian copyright law.
Citation for previous publication

File Details

Date Uploaded
Date Modified
2017-08-04T14:35:15.371+00:00
Audit Status
Audits have not yet been run on this file.
Characterization
File format: pdf (PDF/X)
Mime type: application/pdf
File size: 1266072
Last modified: 2017:11:08 16:40:27-07:00
Filename: Alotaibi_Dhaifallah_S_201708_MSc.pdf
Original checksum: 045e8b4425c98105ce2263bff65f3418
Activity of users you follow
User Activity Date